Le site du Docteur Miguel-Angel CORTES-MORICHETTI

Conventionnement : Secteur 1

Association Between a Cell-Seeded Collagen Matrix and Cellular

 The objective of cellular cardiomyoplasty is to regenerate the myocardium using implantation of living cells. Because the extracellular myocardial matrix is deeply altered in ischemic cardiomyopathies, it could be important to create a procedure aiming at regenerating both myocardial cells and the extracellular matrix. We evaluated the potential of a collagen matrix seeded with cells and grafted onto infarcted ventricles. A myocardial infarction was created in 45 mice using coronary artery ligation. Animals were randomly assigned to 4 local myocardial treatment groups. Group I underwent sham treatment (injection of cell culture medium). Group II underwent injection of human umbilical cord blood mononuclear cells (HUCBCs). Group III underwent injection of HUCBCs and fixation onto the epicardium of a collagen matrix seeded with HUCBCs. Group IV underwent fixation of collagen matrix (without cells) onto the infarct. Echocardiography was performed on postoperative days 7 and 45, followed by histological studies. Echocardiography showed that the association between the cell-loaded matrix and the intrainfarct cell implants was the most efficient approach to limiting postischemic ventricular dilation and remodeling. Ejection fraction improved in both cell-treated groups. The collagen matrix alone did not improve left ventricular (LV) function and remodeling. Histology in Group III showed fragments of the collagen matrix thickening and protecting the infarct scars. Segments of the matrix were consistently aligned along the LV wall, and cells were assembled within the collagen fibers in large populations. Intramyocardial injection of HUCBCs preserves LV function following infarction. The use of a cell-seeded matrix combined with cell injections prevents ventricular wall thinning and limits postischemic remodeling. This tissue engineering approach seems to improve the efficiency of cellular cardiomyoplasty and could emerge as a new therapeutic tool for the prevention of adverse remodeling and progressive heart failure.

Cabinet de Cardiologie de Poissy

3 Rue de l'Abbaye ,
78300 Poissy, France


  • Fixe : 0130740603
  • Fax : 0130657236
Plus d'informations (Accès, Horaire...)

Cabinet des Spécialistes de Verneuil

45 Grande Rue ,
78480 Verneuil-sur-Seine, France


  • Fixe : 0139716005
Plus d'informations (Accès, Horaire...)

Documents similaires

  • Autologous Myoblast Transplantation

     This study was designed to assess whether post-myocardial infarction (MI) in-scar transplantation of skeletal myoblasts could reduce chronic ischemic mitral regurgitation by decreasing left ventricular remodeling. 

    Lire la suite
  • MRI Evaluation of Local Myocardial Treatments

     MRI allows evaluation of the extent of local myocardial treatments. The differences shown between epicardial and endocardial injections concerning the distribution of SPIO can be justified by the methodology of injection and by a more precise MI detection by electrophysiology. In conclusion, electrophysiological recordings to guide injections is superior to direct surgical visualization in terms of injecting into infarcted tissue.

    Lire la suite
  • Journal of Theoretical Biology, Volume 250, Issue 1, 7 January 2008, Pages 92-102

     Increased entropy production in diaphragm muscle of PPARα knockout mice Journal of Theoretical Biology, Volume 250, Issue 1, 7 January 2008, Pages 92-102 Y. Lecarpentier, X. Krokidis, P. Martin, T. Pineau, J.-L. Hébert, J. Quillard, M. Cortes-Morichetti, C. Coirault

    Lire la suite
  • Actomyosin interactions in cMYBP-C−/− mice

     The precise role of cardiac myosin binding protein C (cMyBP-C) on contractility and on actomyosin interaction (AMI) remains unknown. We hypothesized that the lack of cMyBP-C impaired cardiac AMI. Mechanical properties and AMI characteristics in left papillary muscle and the in vitro motility of actin filaments on purified myosin molecules were performed from 16-weeks old cMyBP-C−/−KO and WT (n = 16 in both groups). Compared to WT, both total tension and maximum shortening velocity were lower in KO (p < 0.001). The probability of cross-bridge attachment was higher in KO than in WT (8.6 ± 0.3 vs. 5.4 ± 0.2%, p < 0.05). The number of active AIM was lower in KO (6.4 ± 0.9 vs. 11.6 ± 1.0 109/mm2, p < 0.001) as well as the unitary force per AIM (p < 0.01). Power stroke probability was reduced in KO compared to WT (5.0 ± 0.4 vs. 8.1 ± 0.4%, p < 0.05). Myosin-based velocities of actin were slower in KO than in WT (1.65 ± 0.01 vs. 1.98 ± 0.01 μm/s, p < 0.01). These data suggest that cMyBP-C regulates AIM by limiting inefficient cross-bridge formation and by enhancing the power stroke step.

    Lire la suite
  • Myocardial Assistance by Grafting a New Bioartificial Myocardium

     Cell transplantation for the regeneration of ischemic myocardium is limited by poor graft viability and low cell retention. In ischemic cardiomyopathy the extracellular matrix is deeply altered; therefore, it could be important to associate a procedure aiming at regenerating myocardial cells and restoring the extracellular matrix function. We evaluated intrainfarct cell therapy associated with a cell-seeded collagen scaffold grafted onto infarcted ventricles. In 15 patients (aged 54.2 ± 3.8 years) presenting LV postischemic myocardial scars and with indication for a single OP-CABG, autologous mononuclear bone marrow cells (BMC) were implanted during surgery in the scar. A 3D collagen type I matrix seeded with the same number of BMC was added on top of the scarred area. There was no mortality and no related adverse events (follow-up 15 ± 4.2 months). NYHA FC improved from 2.3 ± 0.5 to 1.4 ± 0.3 (p = 0.005). LV end-diastolic volume evolved from 142 ± 24 to 117 ± 21 ml (p = 0.03), and LV filling deceleration time improved from 162 ± 7 to 196 ± 8 ms (p = 0.01). Scar area thickness progressed from 6 ± 1.4 to 9 ± 1.5 mm (p = 0.005). EF improved from 25 ± 7% to 33 ± 5% (p = 0.04). Simultaneous intramyocardial injection of mononuclear bone marrow cells and fixation of a BMC-seeded matrix onto the epicardium is feasible and safe. The cell-seeded collagen matrix seems to increase the thickness of the infarct scar with viable tissues and helps to normalize cardiac wall stress in injured regions, thus limiting ventricular remodeling and improving diastolic function. Patients’ improvements cannot be conclusively related to the cells and matrix due to the association of CABG. Cardiac tissue engineering seems to extend the indications and benefits of stem cell therapy in cardiology, becoming a promising way for the creation of a “bioartificial myocardium.” Efficacy and safety of this approach should be evaluated in a large randomized controlled trial.

    Lire la suite

Ce site n'a pas pour vocation de remplacer une consultation médicale